{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:46:17Z","timestamp":1782719177833,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine","award":["Grant No. WDCM2024024"],"award-info":[{"award-number":["Grant No. WDCM2024024"]}]},{"name":"the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine","award":["Grant No. WDCM2024023"],"award-info":[{"award-number":["Grant No. WDCM2024023"]}]},{"name":"the Open Project of Hubei Clinical Research Center of Hypertension","award":["Grant No. HBCH2024005"],"award-info":[{"award-number":["Grant No. HBCH2024005"]}]},{"name":"the Science and Technology Foundation of Shiyan City","award":["Grant No. 25Y161"],"award-info":[{"award-number":["Grant No. 25Y161"]}]},{"name":"the Science and Technology Foundation of Shiyan City","award":["Grant No. 25Y165"],"award-info":[{"award-number":["Grant No. 25Y165"]}]},{"name":"the Sinopharm Dongfeng General Hospital Excellence Program Project","award":["Grant No. 2023Q05"],"award-info":[{"award-number":["Grant No. 2023Q05"]}]},{"name":"the Sinopharm Dongfeng General Hospital Excellence Program Project","award":["Grant No. 2024Y01"],"award-info":[{"award-number":["Grant No. 2024Y01"]}]},{"name":"the Natural Science Foundation of Hubei Provincial Department","award":["Grant No. 2025AFB548"],"award-info":[{"award-number":["Grant No. 2025AFB548"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49828-x","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:47:11Z","timestamp":1777362431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory effect of borax on murine hepatocellular carcinoma induced by diethylnitrosamine"],"prefix":"10.1038","volume":"16","author":[{"given":"Hang","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ke","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"1","key":"49828_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12967-024-05230-7","volume":"22","author":"AM El-Derby","year":"2024","unstructured":"El-Derby, A. M. et al. Plasma-derived extracellular matrix for xenofree and cost-effective organoid modeling for hepatocellular carcinoma[J]. J. translational Med. 22 (1), 487 (2024).","journal-title":"J. translational Med."},{"issue":"3","key":"49828_CR2","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s10528-023-10527-1","volume":"62","author":"R Huang","year":"2024","unstructured":"Huang, R. et al. Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting Difference[J]. Biochem. Genet. 62 (3), 2279\u20132295 (2024).","journal-title":"Biochem. Genet."},{"issue":"21","key":"49828_CR3","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.3390\/cancers13215586","volume":"13","author":"T S\u00fckei","year":"2021","unstructured":"S\u00fckei, T., Palma, E. & Urbani, L. Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma[J]. Cancers 13 (21), 5586 (2021).","journal-title":"Cancers"},{"issue":"3","key":"49828_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","volume":"34","author":"H Gilles","year":"2022","unstructured":"Gilles, H., Garbutt, T. & Landrum, J. Hepatocellular Carcinoma[J]. Crit. Care Nurs. Clin. N. Am. 34 (3), 289\u2013301 (2022).","journal-title":"Crit. Care Nurs. Clin. N. Am."},{"issue":"4","key":"49828_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/ijmm.2022.5107","volume":"49","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. A pre\u2013clinical model combining cryopreservation technique with precision\u2013cut slice culture method to assess the in vitro drug response of hepatocellular carcinoma[J]. Int. J. Mol. Med. 49 (4), 51 (2022).","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"49828_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/ol.2020.12319","volume":"21","author":"G Hong","year":"2021","unstructured":"Hong, G. et al. Innate immune cells and their interaction with T cells in hepatocellular carcinoma[J]. Oncol. Lett. 21 (1), 57 (2021).","journal-title":"Oncol. Lett."},{"issue":"20","key":"49828_CR7","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1158\/0008-5472.CAN-22-3115","volume":"83","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti-PD-1 Immunotherapy[J]. Cancer Res. 83 (20), 3385\u20133399 (2023).","journal-title":"Cancer Res."},{"issue":"12","key":"49828_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00262-019-02427-4","volume":"68","author":"B Langhans","year":"2019","unstructured":"Langhans, B. et al. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma[J]. Cancer Immunol. immunotherapy: CII. 68 (12), 2055\u20132066 (2019).","journal-title":"Cancer Immunol. immunotherapy: CII"},{"key":"49828_CR9","doi-asserted-by":"crossref","unstructured":"Keindl, M. et al. Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sj\u00f6gren\u2019s syndrome[J] Vol. 24, 101 (Arthritis research & therapy, 2022). 1.","DOI":"10.1186\/s13075-022-02769-y"},{"issue":"1","key":"49828_CR10","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis[J]. Nat. Commun. 14 (1), 5123 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"49828_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4\u2009+\u2009CD25+ regulatory T cells[J]. Nat. Immunol. 4 (4), 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"49828_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi, S. et al. Foxp3\u2009+\u2009CD25+ CD4\u2009+\u2009natural regulatory T cells in dominant self-tolerance and autoimmune disease[J]. Immunol. Rev. 212, 8\u201327 (2006).","journal-title":"Immunol. Rev."},{"issue":"7","key":"49828_CR13","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.4049\/jimmunol.171.7.3435","volume":"171","author":"A Antov","year":"2003","unstructured":"Antov, A. et al. Essential role for STAT5 signaling in CD25\u2009+\u2009CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance[J]. J. Immunol. (Baltimore Md. : 1950). 171 (7), 3435\u20133441 (2003).","journal-title":"J. Immunol. (Baltimore Md. : 1950)"},{"issue":"7","key":"49828_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/PAS.0b013e31824e9b7c","volume":"36","author":"AM Mathai","year":"2012","unstructured":"Mathai, A. M. et al. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma[J]. Am. J. Surg. Pathol. 36 (7), 980\u2013986 (2012).","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"49828_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4103\/0377-4929.85073","volume":"54","author":"S Thakur","year":"2011","unstructured":"Thakur, S. et al. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study[J]. Indian. J. Pathol. Microbiol. 54 (3), 448\u2013453 (2011).","journal-title":"Indian. J. Pathol. Microbiol."},{"issue":"12","key":"49828_CR16","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1002\/eji.200323966","volume":"33","author":"NOS C\u00e2mara","year":"2003","unstructured":"C\u00e2mara, N. O. S., Sebille, F. & Lechler, R. I. Human CD4\u2009+\u2009CD25+ regulatory cells have marked and sustained effects on CD8\u2009+\u2009T cell activation[J]. Eur. J. Immunol. 33 (12), 3473\u20133483 (2003).","journal-title":"Eur. J. Immunol."},{"key":"49828_CR17","doi-asserted-by":"crossref","unstructured":"Casares, N. et al. CD4+\/CD25\u2009+\u2009regulatory cells inhibit activation of tumor-primed CD4\u2009+\u2009T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination[J]. Journal of immunology (Baltimore, Md.: 2003,171(11):5931\u20135939. (1950).","DOI":"10.4049\/jimmunol.171.11.5931"},{"key":"49828_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CMAR.S105163","volume":"9","author":"M Mohan","year":"2017","unstructured":"Mohan, M., Matin, A. & Davies, F. E. Update on the optimal use of bortezomib in the treatment of multiple myeloma[J]. Cancer Manage. Res. 9, 51\u201363 (2017).","journal-title":"Cancer Manage. Res."},{"key":"49828_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jtemb.2016.04.007","volume":"36","author":"TV Bhasker","year":"2016","unstructured":"Bhasker, T. V. et al. Boron influences immune and antioxidant responses by modulating hepatic superoxide dismutase activity under calcium deficit abiotic stress in Wistar rats[J]. J. trace Elem. Med. biology: organ. Soc. Minerals Trace Elem. (GMS). 36, 73\u201379 (2016).","journal-title":"J. trace Elem. Med. biology: organ. Soc. Minerals Trace Elem. (GMS)"},{"issue":"1","key":"49828_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12011-018-1284-3","volume":"186","author":"H Khaliq","year":"2018","unstructured":"Khaliq, H., Juming, Z. & Ke-Mei, P. The Physiological Role of Boron on Health[J]. Biol. Trace Elem. Res. 186 (1), 31\u201351 (2018).","journal-title":"Biol. Trace Elem. Res."},{"issue":"4","key":"49828_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.exphem.2015.05.019","volume":"44","author":"AP Ercetin","year":"2016","unstructured":"Ercetin, A. P. et al. Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma[J]. Exp. Hematol. 44 (4), 223\u2013230 (2016).","journal-title":"Exp. Hematol."},{"issue":"16","key":"49828_CR22","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1182\/blood-2012-09-456889","volume":"123","author":"K Gupta","year":"2014","unstructured":"Gupta, K. et al. Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells[J]. Blood 123 (16), 2550\u20132561 (2014).","journal-title":"Blood"},{"issue":"3","key":"49828_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00277-017-3203-7","volume":"97","author":"X Qin","year":"2018","unstructured":"Qin, X. et al. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens[J]. Ann. Hematol. 97 (3), 485\u2013495 (2018).","journal-title":"Ann. Hematol."},{"key":"49828_CR24","doi-asserted-by":"publisher","first-page":"127052","DOI":"10.1016\/j.jtemb.2022.127052","volume":"74","author":"Y Wei","year":"2022","unstructured":"Wei, Y. et al. Boron attenuated diethylnitrosamine induced hepatocellular carcinoma in C3H\/HeN mice via alteration of oxidative stress and apoptotic pathway[J]. J. trace Elem. Med. biology: organ. Soc. Minerals Trace Elem. (GMS). 74, 127052 (2022).","journal-title":"J. trace Elem. Med. biology: organ. Soc. Minerals Trace Elem. (GMS)"},{"issue":"7","key":"49828_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/cancers16071422","volume":"16","author":"J Du","year":"2024","unstructured":"Du, J., Hsu, S. & Wang, S. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma[J]. Cancers 16 (7), 1422 (2024).","journal-title":"Cancers"},{"key":"49828_CR26","unstructured":"Pizzorno, L. Nothing Boring About Boron[J]. Integrative medicine (Encinitas, Calif.), 14(4):35\u201348. (2015)."},{"issue":"2","key":"49828_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.abb.2012.11.008","volume":"529","author":"H Zafar","year":"2013","unstructured":"Zafar, H. & Ali, S. Boron inhibits the proliferating cell nuclear antigen index, molybdenum containing proteins and ameliorates oxidative stress in hepatocellular carcinoma[J]. Arch. Biochem. Biophys. 529 (2), 66\u201374 (2013).","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"49828_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/14653240701247853","volume":"9","author":"X Lu","year":"2007","unstructured":"Lu, X. et al. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells[J]. Cytotherapy 9 (3), 292\u2013300 (2007).","journal-title":"Cytotherapy"},{"issue":"2","key":"49828_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/mc.22269","volume":"55","author":"M Illemann","year":"2016","unstructured":"Illemann, M. et al. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures[J]. Mol. Carcinog. 55 (2), 193\u2013208 (2016).","journal-title":"Mol. Carcinog."},{"issue":"1","key":"49828_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21037\/jgo.2017.06.08","volume":"9","author":"S Lee","year":"2018","unstructured":"Lee, S., Loecher, M. & Iyer, R. Immunomodulation in hepatocellular cancer[J]. J. Gastrointest. Oncol. 9 (1), 208\u2013219 (2018).","journal-title":"J. Gastrointest. Oncol."},{"key":"49828_CR31","unstructured":"Schabowsky, R. et al. Targeting CD4\u2009+\u2009CD25+FoxP3\u2009+\u2009regulatory T-cells for the augmentation of cancer immunotherapy[J]. Current opinion in investigational drugs (London, England: 2007,8(12):1002\u20131008. (2000)."},{"key":"49828_CR32","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2147\/JAA.S321616","volume":"14","author":"Y Song","year":"2021","unstructured":"Song, Y. et al. Sophora flavescens Alkaloids and Corticosteroid Synergistically Augment IL-10\/IL-5 Ratio with Foxp3-Gene-Epigenetic Modification in Asthma PBMCs[J]. J. asthma allergy. 14, 1559\u20131571 (2021).","journal-title":"J. asthma allergy"},{"issue":"24","key":"49828_CR33","doi-asserted-by":"publisher","first-page":"e163470","DOI":"10.1172\/JCI163470","volume":"133","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells[J]. J. Clin. Investig. 133 (24), e163470 (2023).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"49828_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential[J]. Signal. Transduct. Target. therapy. 10 (1), 345 (2025).","journal-title":"Signal. Transduct. Target. therapy"},{"issue":"8","key":"49828_CR35","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1007\/s12011-021-02983-w","volume":"200","author":"C Zhao","year":"2022","unstructured":"Zhao, C. et al. Transcriptome Profiling of Duodenum Reveals the Importance of Boron Supplementation in Modulating Immune Activities in Rats[J]. Biol. Trace Elem. Res. 200 (8), 3762\u20133773 (2022).","journal-title":"Biol. Trace Elem. Res."},{"key":"49828_CR36","doi-asserted-by":"publisher","first-page":"110432","DOI":"10.1016\/j.cbi.2023.110432","volume":"376","author":"E Calabrese","year":"2023","unstructured":"Calabrese, E. et al. Boron enhances adaptive responses and biological performance via hormetic mechanisms[J]. Chemico-Biol. Interact. 376, 110432 (2023).","journal-title":"Chemico-Biol. Interact."},{"key":"49828_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fimmu.2019.00913","volume":"10","author":"R Yang","year":"2019","unstructured":"Yang, R. et al. IL-12 Expands and Differentiates Human V\u03b32V\u03b42 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth[J]. Front. Immunol. 10, 913 (2019).","journal-title":"Front. Immunol."},{"issue":"3","key":"49828_CR38","doi-asserted-by":"publisher","first-page":"e12971","DOI":"10.1111\/pim.12971","volume":"45","author":"CM Sandoval Pacheco","year":"2023","unstructured":"Sandoval Pacheco, C. M. et al. Role of antigen-presenting cells in non-ulcerated skin lesions caused by Leishmania (Leishmania) infantum chagasi[J]. Parasite Immunol. 45 (3), e12971 (2023).","journal-title":"Parasite Immunol."},{"issue":"10","key":"49828_CR39","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1111\/cas.16298","volume":"115","author":"T Fujimoto","year":"2024","unstructured":"Fujimoto, T. et al. Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron immunotherapy (B-NIT)[J]. Cancer Sci. 115 (10), 3231\u20133247 (2024).","journal-title":"Cancer Sci."},{"issue":"4","key":"49828_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/jir.2015.0054","volume":"36","author":"A Rani","year":"2016","unstructured":"Rani, A. & Murphy, J. J. STAT5 in Cancer and Immunity[J]. J. interferon cytokine research: official J. Int. Soc. Interferon Cytokine Res. 36 (4), 226\u2013237 (2016).","journal-title":"J. interferon cytokine research: official J. Int. Soc. Interferon Cytokine Res."},{"issue":"1","key":"49828_CR41","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/s41598-020-80935-5","volume":"11","author":"C Teng","year":"2021","unstructured":"Teng, C. et al. Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant[J]. Sci. Rep. 11 (1), 1136 (2021).","journal-title":"Sci. Rep."},{"issue":"16","key":"49828_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.21037\/atm.2019.07.45","volume":"7","author":"Q Mao","year":"2019","unstructured":"Mao, Q. et al. Immunoregulatory role of IL-2\/STAT5\/CD4\u2009+\u2009CD25+Foxp3 Treg pathway in the pathogenesis of chronic osteomyelitis[J]. Annals translational Med. 7 (16), 384 (2019).","journal-title":"Annals translational Med."},{"issue":"8","key":"49828_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.14348\/molcells.2022.2056","volume":"45","author":"G Kim","year":"2022","unstructured":"Kim, G. & Choi, J. Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy[J]. Mol. Cells. 45 (8), 513\u2013521 (2022).","journal-title":"Mol. Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49828-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49828-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:09:56Z","timestamp":1782716996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49828-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49828"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49828-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19655"}}